Therapeutic Delivery – Multimedia

This eBook equips developers with essential knowledge to make informed decisions about lipid selection for LNP formulations.

Since its discovery 20 years ago, graphene has been a hot topic in materials science. But its potential uses span many more disciplines, including drug delivery, engineering, biosensing, energy, electronics and more.

This guide highlights key concepts in LNP formulation, offering step-by-step procedures and insights to optimize delivery outcomes.

This article explores how scientists are tackling the challenges and intensifying efforts to develop mRNA therapeutics for different diseases.

The pandemic has ushered in a vaccine “golden era”. Long-term investment in vaccine manufacturing has been prioritized, as has the pursuit of novel vaccine platforms. We explore recent advances in vaccine research and development.

According to the World Health Organization (WHO), cancer is a leading cause of death worldwide. Furthermore, recent estimates predict that as many as one in two people could develop a form of cancer in their lifetime.

Developing mRNA-based therapeutics is complex work, requiring highly skilled scientists, high-tech microfluidics platforms and sophisticated analytical equipment, and of course the mRNA itself.

Lipid nanoparticles (LNPs) have emerged as effective delivery vehicles for mRNA vaccines and nucleic acid-based drugs. Hence, the analysis of their composition, stability, and biological interactions is essential in drug development and delivery.

Liposomes are spherical vesicle having at least one lipid bilayer. Liposomes can be used as a vehicle (delivery system) for the administration of nutrients and pharmaceutical drugs.

Speaking at the Vaccine Research & Development 2022 online symposium, Nikolai Petrovsky, Professor of Medicine at FLinder's University, delivered his talk on the first Australian-developed vaccine in over 40 years.